These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2498203)

  • 1. A simple method for preparation of good quality cryoprecipitate.
    De M; Banerjee D; Chandra S; Bhattacharya DK
    Indian J Med Res; 1989 Feb; 90():32-5. PubMed ID: 2498203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of cryoprecipitate from riboflavin and UV light-treated plasma.
    Ettinger A; Miklauz MM; Bihm DJ; Maldonado-Codina G; Goodrich RP
    Transfus Apher Sci; 2012 Apr; 46(2):153-8. PubMed ID: 22342281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freezing of plasma and recovery of factor VIII.
    Carlebjörk G; Blombäck M; Pihlstedt P
    Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of human thrombin for use in a fibrin glue.
    Rock G; Neurath D; Semple E; Harvey M; Freedman M
    Transfus Med; 2007 Jun; 17(3):187-91. PubMed ID: 17561860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature on plasma freezing under industrial conditions.
    Bravo MI; Grancha S; Jorquera JI
    Pharmeur Sci Notes; 2006 Aug; 2006(1):31-5. PubMed ID: 17694644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.
    Omidkhoda A; Tabatabaei MR; Atarodi K; Karimi K; Froushani AR; Pourfathollah AA
    Blood Transfus; 2011 Oct; 9(4):394-9. PubMed ID: 21839017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of minipooled solvent/detergent-filtered cryoprecipitate factor VIII.
    El-Ekiaby M; Goubran HA; Radosevich M; Abd-Allah A; El-Ekiaby A; Burnouf T
    Haemophilia; 2011 Sep; 17(5):e884-8. PubMed ID: 21371202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of a cryoprecipitate by the thaw and siphon method].
    Daszyński J; Rosiek A; Lopaciuk S
    Acta Haematol Pol; 1985; 16(3-4):139-43. PubMed ID: 3939069
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII-related activities in therapeutic concentrates.
    Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
    J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
    Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
    Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.